Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

RUPATADINE DIN 02572613

Status: Approved
Holder: SANIS HEALTH INC
Molecule: RUPATADINE (RUPATADINE FUMARATE)

Health Canada record

Active ingredient(s)RUPATADINE (RUPATADINE FUMARATE) 10 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCR06AX28 RUPATADINE
Original market date
Current status date14-Oct-2026
SourceHealth Canada DPD

Establishment licence of the holder

Sanis Health Inc. — licence 101796, currently licensed, last inspection rating I (2024-07-23).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing RUPATADINE (RUPATADINE FUMARATE)

DINProductCompanyFormStrengthStatus
02553155APO-RUPATADINEAPOTEX INCTabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02552604PMS-RUPATADINEPHARMASCIENCE INCTabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02560119RIVA-RUPATADINELABORATOIRE RIVA INC.TabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02456451RUPALLMEDEXUS PHARMACEUTICALS INC.TabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02456478RUPALLMEDEXUS PHARMACEUTICALS INC.SolutionRUPATADINE (RUPATADINE FUMARATE) 1 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
384682026-10-14Abbreviated New Drug Submission (ANDS)Administrative: Licensing Agreement between two manufacturers
Request a quote for RUPATADINE

How to read a Canadian DIN record